Why the study?
Do PPAR alpha ligands inhibit endothelin-induced hypertrophy in neonatal rat cardiac myocytes?
Population
Neonatal rat cardiac myocytes stimulated with endothelin to activate the hypertrophic program in vitro
Comparison
PPAR alpha ligands (fenofibrate and WY14,643) vs Endothelin stimulation without PPAR alpha…
Design
Preclinical
Authors
Loading...
Should not change practice; leaves open translation of PPARα effects from neonatal rat myocytes to clinical hypertrophy.
Do PPAR alpha ligands inhibit endothelin-induced hypertrophy in neonatal rat cardiac myocytes?
PPAR alpha ligands suppress endothelin-induced hypertrophy in neonatal rat cardiac myocytes, suggesting potential utility in managing myocardial hypertrophy and remodeling.
Liang et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: